[go: up one dir, main page]

CN1889861B - Alkaline drug inhaler and its manufacturing method - Google Patents

Alkaline drug inhaler and its manufacturing method Download PDF

Info

Publication number
CN1889861B
CN1889861B CN2004800361875A CN200480036187A CN1889861B CN 1889861 B CN1889861 B CN 1889861B CN 2004800361875 A CN2004800361875 A CN 2004800361875A CN 200480036187 A CN200480036187 A CN 200480036187A CN 1889861 B CN1889861 B CN 1889861B
Authority
CN
China
Prior art keywords
suction apparatus
preparation
air
active material
sucking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2004800361875A
Other languages
Chinese (zh)
Other versions
CN1889861A (en
Inventor
米迦勒·霍斯特曼
卡琳·路德维希
克里斯托夫·施米茨
买买提·萨梅特
伊夫-托尔斯滕·普日贝拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of CN1889861A publication Critical patent/CN1889861A/en
Application granted granted Critical
Publication of CN1889861B publication Critical patent/CN1889861B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/20Devices without heating means
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/60Constructional details
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/80Manufacture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0003Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a device, for the administration of basic agents, in particular nicotine, to the human or animal body, by means of inhalation, comprising a first preparation containing nicotine base or/and a further basic agent and, furthermore, a second or further preparations, whereby at least one preparation contains at least one volatile acid suitable for inhalation.

Description

碱性药物吸入器及其制造方法 Alkaline drug inhaler and its manufacturing method

技术领域technical field

本发明涉及通过吸入的方式给予人或动物体碱性活性物质、特别是尼古丁的装置。本发明进一步涉及可以得到该装置的制造方法,以及所述的装置用于戒烟或在必要的情况下用于渴望尼古丁的无烟满足的应用。The present invention relates to a device for administering alkaline active substances, especially nicotine, to the human or animal body by inhalation. The invention further relates to the manufacturing method by which this device can be obtained, and the use of said device for smoking cessation or, if necessary, for the smoke-free gratification of nicotine cravings.

背景技术Background technique

多年以来,借助于吸气中吸入的空气给予尼古丁的尼古丁吸入器已是众所周知的(如美国专利4 917 120和美国专利5 167 242)。多年来,尼古丁吸入器也已在几个欧洲国家的市场上作为戒烟产品可以得到(″Nicorette

Figure 048361875_0
″;Pharmaci/辉瑞)。然而,由于用后一种吸入器,吸入时只有少量的尼古丁变得有效,所以该装置没有得到广泛使用。这特别是由于已知吸入器技术的基本缺陷和用这些技术可以达到的耐受性。特别地,由尼古丁的碱性导致的对呼吸道粘膜的局部刺激作用是不利的,因为这种刺激作用引起急迫的咳嗽,其导致由吸入器释放的尼古丁蒸气的吸收减少。这样只有非常少量的尼古丁被身体吸收。Nicotine inhalers, which deliver nicotine by means of air drawn in during inspiration, have been known for many years (eg US Patent 4 917 120 and US Patent 5 167 242). Over the years, nicotine inhalers have also been available on the market in several European countries as smoking cessation products ("Nicorette
Figure 048361875_0
"; Pharmaci/Pfizer). However, since with the latter inhaler, only a small amount of nicotine becomes effective when inhaled, this device has not been widely used. This is especially due to the fundamental drawbacks of known inhaler technology and the use of these Tolerance achievable by technology. In particular, the local irritation of the mucous membranes of the respiratory tract caused by the alkalinity of nicotine is disadvantageous, since this irritation causes an urgent cough, which leads to the absorption of the nicotine vapor released by the inhaler Reduced. This way only a very small amount of nicotine is absorbed by the body.

发明内容Contents of the invention

所以本发明的目的是提供一种尼古丁吸入器,该吸入器使尼古丁能够经呼吸道吸收,而引起尽可能小的刺激和尽可能深入的吸收。It is therefore an object of the present invention to provide a nicotine inhaler which enables nicotine to be absorbed through the respiratory tract with as little irritation as possible and as deep an absorption as possible.

该目的是根据独立权利要求和其附属权利要求的装置,以及根据权利要求19和其附属权利要求的制备方法实现的。This object is achieved by a device according to the independent claim and its dependent claims, and by a production method according to claim 19 and its dependent claims.

因此,根据本发明的装置特征在于,该装置包括含有尼古丁碱或/和其它挥发性、可吸入的碱性活性物质的第一制剂,且其进一步包括第二制剂或多个其它制剂,所述的第二制剂或所述的其它制剂中的至少一个含有至少一种可挥发及适于吸入的酸。所以,根据本发明的装置特征在于,吸入时,除了活性物质碱(如尼古丁碱)之外,还同时吸入了一种或多种挥发性酸化合物。Thus, the device according to the invention is characterized in that it comprises a first formulation comprising nicotine base or/and other volatile, inhalable basic active substances, and that it further comprises a second formulation or formulations, said At least one of said second formulation or said other formulations contains at least one volatile and inhalable acid. The device according to the invention is therefore characterized in that, during inhalation, one or more volatile acid compounds are simultaneously inhaled in addition to the active substance base (eg nicotine base).

根据本发明的装置适于通过吸入的方式给予人或动物体碱性物质,尤其是尼古丁。适当的碱性物质为,例如司来吉兰(selegiline)或/和美加明(mecamylamine)。尼古丁和美加明的结合特别优选适用于戒烟。The device according to the invention is suitable for administering alkaline substances, especially nicotine, to the human or animal body by inhalation. Suitable basic substances are, for example, selegiline and/or mecamylamine. The combination of nicotine and mecamylamine is particularly preferred for smoking cessation.

由于含有尼古丁碱(或其它活性物质碱)的第一制剂与含有挥发酸的另一制剂同时存在,所以吸入时尼古丁碱和挥发酸被挥发,从而导致碱和酸蒸气的混合物在该装置中形成相应的尼古丁盐(或其它活性物质碱相应的盐)。该盐以液滴或微粒的形式随吸入空气进入呼吸道。由于粘膜对盐的中性反应,所以与用已知的吸入装置可以达到的吸入相比,这类吸入显示出更好的耐受性。As a result of the simultaneous presence of a first formulation containing nicotine base (or other active substance base) with another formulation containing volatile acid, the nicotine base and volatile acid are volatilized during inhalation, causing a mixture of base and acid vapors to form in the device The corresponding nicotine salt (or the corresponding salt of other active substance base). The salt enters the airways in the form of droplets or fine particles with inhaled air. Due to the neutral reaction of the mucous membranes to salt, inhalation of this type is shown to be better tolerated than inhalation achievable with known inhalation devices.

关于这一点,优选所述的含有尼古丁碱的第一制剂,和含有酸的第二制剂在装置内分开的位置处使用。这样,可以设定空气进气道,从而在吸入时,一部分气流流经第一制剂,而另一部分气流流经第二制剂,且随后这两个气流(其中含有挥发的尼古丁碱和酸)合并,然后可被吸入。In this regard, it is preferred that said first formulation comprising nicotine base and said second formulation comprising acid are used at separate locations within the device. In this way, the air inlet can be set so that on inhalation, part of the airflow passes through the first formulation, while another part flows through the second formulation, and then the two streams (which contain the volatile nicotine base and acid) combine , which can then be inhaled.

吸入时,包含于第一制剂中的活性物质碱(如尼古丁碱)和包含于第二制剂中的挥发酸被动地挥发。可通过采用加热选择性地加速该过程;适用于该目的的方法对于本领域的技术人员是公知的。Upon inhalation, the active substance base (such as nicotine base) contained in the first formulation and the volatile acid contained in the second formulation are passively volatilized. The process can optionally be accelerated by the use of heat; methods suitable for this purpose are well known to those skilled in the art.

当使用根据本发明的装置时,在流入的外界空气中形成气溶胶,尤其是当在蒸气中具有高浓度的活性物质碱和酸时。该气雾剂的形成是由于形成的尼古丁盐、盐混合物或盐液滴的较低的挥发性。由于尼古丁不再以游离碱存在且不再经由外气相起到碱的作用,所以形成的气溶胶同时也是显著提高耐受性的原因。结果,只有气雾剂颗粒在肺泡的微粒沉积可以导致活性物质在肺中应用和吸收(再吸收)。这些气雾剂小滴,或者作为部分溶于水的盐组分,或者作为固体分散物,由于中性(代替碱性的)粘膜反应,显示出远好于本领域中已知的装置可能显示出的耐受性。气溶胶形成是有益的,但对于实现根据本发明的治疗效果不是必不可少的。总的来说,抑制气溶胶的形成的供给蒸气的高度稀释,在耐受性方面也是有用的。When using the device according to the invention, aerosols are formed in the inflowing ambient air, especially when there is a high concentration of active substances bases and acids in the vapor. The aerosol formation is due to the lower volatility of the formed nicotine salt, salt mixture or salt droplets. Since nicotine is no longer present as a free base and no longer acts as a base via the external gas phase, the aerosols formed are at the same time responsible for a marked increase in tolerance. As a result, only the particulate deposition of aerosol particles in the alveoli can lead to application and absorption (reabsorption) of the active substance in the lungs. These aerosol droplets, either as a partially water-soluble salt component, or as a solid dispersion, exhibit far better mucous membrane response than devices known in the art may exhibit due to neutral (instead of basic) mucosal responses. out of tolerance. Aerosol formation is beneficial but not essential to achieve the therapeutic effect according to the invention. In general, a high dilution of the supplied vapor, which suppresses the formation of aerosols, is also useful in terms of tolerance.

通过根据本发明的吸入系统形成的气雾剂微粒的尺寸,最重要的是取决于气流的速度(流速)和混合区中各气态组分(分别为碱性活性物质和酸)的浓度。气雾剂微粒的尺寸低于10μm(平均直径),特别在5~10μm内是有利于肺泡吸收的。The size of the aerosol particles formed by the inhalation system according to the invention depends above all on the velocity of the gas flow (flow rate) and the concentration of the individual gaseous components (respectively alkaline active substance and acid) in the mixing zone. The size of aerosol particles is less than 10 μm (average diameter), especially within 5-10 μm, which is beneficial to alveolar absorption.

根据优选实施方案,吸入装置包括第一进气孔,第二进气孔和出气孔。设置这些孔以使流经第一进气孔的气流主要通过所述的第一制剂,且流经第二进气孔的气流主要通过所述的第二或其它制剂,这两个气流随后在其路径上合并,并经过所述的出气孔离开装置。According to a preferred embodiment, the inhalation device comprises a first air inlet opening, a second air inlet opening and an air outlet opening. These holes are arranged so that the airflow flowing through the first air inlet mainly passes through the first agent, and the airflow flowing through the second air inlet mainly passes through the second or other agent, and these two airflows are then in Merge on its path and leave the device through said vent hole.

该装置进一步优选在其内具有长方形凹部、槽或沟,从而形成第一和第二进气道和出气道。这些气流路径分别各通过所述的进气和出气口朝着外面开放。所述的第一制剂设置于形成第一进气道的长方形凹部中,且所述的第二制剂设置于形成第二进气道的长方形凹部中。优选将各制剂置于各自进气口的邻近处。The device further preferably has a rectangular recess, groove or channel therein forming the first and second inlet and outlet channels. These airflow paths are respectively open towards the outside through said air inlet and air outlet. The first preparation is arranged in the rectangular recess forming the first air inlet, and the second preparation is arranged in the rectangular recess forming the second air inlet. Preferably, each formulation is placed adjacent to a respective gas inlet.

通常,希望达到两个组分(活性物质碱、酸)的约等摩尔比值的摩尔蒸发速率。正如所述,如果含有尼古丁的制剂和含有酸的制剂被放置于两个分开的进气道中,其具有结合的进气口,则可以控制各自的释放速率,尤其是通过两个槽中的流动条件的方式。例如,可以设定流经第一开口和由此流经第一进气道的气流的释放速率为100μg/10s;在此情况下,如果使用醋酸作为酸组分,则大约50mg/10s的释放速率将适于所述的第二气流。In general, molar evaporation rates of approximately equimolar ratios of the two components (active substance base, acid) are desired. As stated, if the nicotine-containing formulation and the acid-containing formulation are placed in two separate inlets with combined inlets, the respective release rates can be controlled, especially by the flow in the two slots conditional way. For example, a release rate of 100 μg/10s can be set for the airflow flowing through the first opening and thus the first inlet; The rate will be suitable for said second gas flow.

关于可得到的释放速率,优选在持续1~10s、且其间达到0.1~1l/min的吸气速度的一次吸气过程中,根据本发明的吸入装置从所述的制剂向吸入的空气中释放5~250μg,优选10~100μg的尼古丁碱或另一碱性物质。例如,在持续10s且吸气速度在0.1~1l/min之间的一次呼吸中,可以给予100μg的尼古丁碱;该释放速率适于治疗目的。With regard to the release rate achievable, the inhalation device according to the invention releases from said formulation into the inhaled air during one inhalation lasting 1-10 s, during which an inspiratory velocity of 0.1-1 l/min is achieved 5-250 μg, preferably 10-100 μg, of nicotine base or another basic substance. For example, 100 μg of nicotine base may be administered in one breath lasting 10 s at an inspiratory rate between 0.1 and 1 l/min; this rate of release is suitable for therapeutic purposes.

为了尽可能少地削弱吸气过程,该装置优选具有贯穿其构造的大的通道横截面。这尤其应用于下面的情况,使进气孔和出气孔的管道横截面形成为使在吸气过程中口腔中的负分压不超过300Pa。In order to impair the inhalation process as little as possible, the device preferably has a large channel cross-section throughout its design. This applies in particular when the duct cross-sections of the inlet and outlet holes are formed such that the negative partial pressure in the oral cavity does not exceed 300 Pa during inhalation.

作为挥发酸,优选使用醋酸;也可以使用其它酸,如果它们在室温(约15~25℃)下是可挥发的或在热(高达约100℃)影响下可以转变成气相(例如乳酸、苹果酸、丙酸)。也可以使用不同酸的组合。醋酸由于其高挥发性,以较低的浓度和较大的总量使用,也可以与添加剂结合使用。挥发性、可吸入碱性活性物质尤其是指在上述温度下挥发性的、或可以转变成气相的物质。As volatile acid, acetic acid is preferably used; other acids can also be used if they are volatile at room temperature (approx. acid, propionic acid). Combinations of different acids can also be used. Acetic acid, due to its high volatility, is used in lower concentrations and in larger total quantities, and can also be used in combination with additives. Volatile, respirable basic active substances especially mean substances which are volatile at the abovementioned temperatures or which can be transformed into the gas phase.

此外,根据具体的实施方案,含有活性物质的制剂另外包含至少一种适于吸入的溶剂(优选乙醇)或/和至少一种挥发性辅助物质(优选薄荷醇)。含有酸的制剂可以同样包含至少一种这种溶剂或/和至少一种挥发性辅助物质。适当的挥发性辅助物质尤其是使人感到愉快的香料和调味剂(如柠檬油精、桉油精、薄荷油、樟脑或萜类的其它物质;包括前述物质的结合)。Furthermore, according to a particular embodiment, the active substance-containing formulation additionally comprises at least one solvent suitable for inhalation (preferably ethanol) or/and at least one volatile auxiliary substance (preferably menthol). Acid-containing formulations may likewise comprise at least one such solvent or/and at least one volatile auxiliary substance. Suitable volatile auxiliary substances are especially pleasant fragrances and flavorings (eg limonene, eucalyptol, peppermint oil, camphor or other substances of the terpenoid type; including combinations of the foregoing).

本发明进一步包括上述装置的制造方法。这些方法通常包括以下步骤:The present invention further includes a method of manufacturing the above device. These methods usually include the following steps:

通过深拉法或其它本领域中公知的加工方法(如注塑法)制造成形部件,所述的成形部件包括接收所述第一制剂的第一长形凹部,及接收所述第二制剂的第二长形凹部;Manufacture a shaped part by deep drawing or other processing methods known in the art (such as injection molding), said shaped part comprising a first elongated recess to receive said first formulation, and a first elongated recess to receive said second formulation. Two elongated recesses;

将预定量的含有尼古丁碱或另一碱性活性物质的第一制剂放入所述的第一凹槽中;placing a predetermined amount of a first formulation containing nicotine base or another basic active substance into said first recess;

将预定量的含有酸的第二制剂放入所述的第二凹槽中。A predetermined amount of the second acid-containing formulation is placed into the second groove.

根据本发明的装置通过使用由深拉法制造的成形部件可以简单的方式及低成本制造。适合于该目的的优选材料为具有碱性物质,尤其是尼古丁不渗透的涂层的聚酯材料。首要适于此目的的为丙烯腈和甲基丙烯酸酯(Barex

Figure 048361875_1
;英国)的共聚物。优选使用聚对苯二甲酸乙二醇酯-Barex层压板。The device according to the invention can be produced in a simple and cost-effective manner by using shaped parts produced by deep drawing. A preferred material suitable for this purpose is a polyester material with a coating impermeable to alkaline substances, especially nicotine. Primarily suitable for this purpose are acrylonitrile and methacrylate (Barex
Figure 048361875_1
; UK) copolymers. Preference is given to using a polyethylene terephthalate-Barex laminate.

通过深拉法的手段,在形成两个进气道的成形部件内提供了凹部。此外,可以提供与所述的两个凹部连接且形成出气道的另外的凹部。进气道和出气道具有基本上圆柱形的结构,但是它们也可以具有不同的几何形状。By means of deep drawing, recesses are provided in the shaped part forming the two air inlet channels. Furthermore, a further recess may be provided which is connected to the two recesses described and forms the outlet channel. The inlet and outlet channels have an essentially cylindrical configuration, but they can also have different geometries.

具有凹部的成形部件形成装置的底部;上部可以通过具有相应地提供的凹槽的第二成形部件,或通过作为盖的平面膜或层形成。放入制剂后,上部和底部以已知的方式(如胶接、焊接)彼此连接。A shaped part with a recess forms the bottom of the device; the upper part can be formed by a second shaped part with correspondingly provided grooves, or by a planar film or layer as a cover. After being placed in the formulation, the upper part and the lower part are connected to each other in a known manner (eg gluing, welding).

可以通过提供另外的突起(其同样可以用深拉法制造)使在成形部件中形成进气道的凹部或成形部件安置,以使各挥发性组分的汽化速率可以在几何学上被限制。此方法另外还可以实现优选以等摩尔量递送活性物质碱和酸。Recesses or shaped parts forming the inlet channels in the shaped part can be accommodated by providing additional protrusions, which can likewise be produced by deep-drawing, so that the vaporization rate of the individual volatile components can be limited geometrically. This method additionally makes it possible to deliver the active substance base and acid preferably in equimolar amounts.

该装置至少部分地,但优选完全地由对于活性物质不渗透的材料,尤其由具有上述涂层的聚酯材料,和/或由金属箔,或这些材料的组合制造。The device is manufactured at least partially, but preferably completely, from a material impermeable to the active substance, especially from a polyester material with the above-mentioned coating, and/or from a metal foil, or a combination of these materials.

适于作为制备上述制剂的基质原则上为可以用于制备接收尼古丁碱或其它活性物质碱或所述的挥发酸的贮库的任何材料,并且所制得的贮库在吸入条件下,通过汽化向周围空气中释放这些物质。适于此目的的材料对于本领域的技术人员是已知的。Suitable as substrates for the preparation of the above formulations are in principle any material which can be used for the preparation of depots which receive nicotine base or other active substance bases or said volatile acids, and the prepared depots are subjected to vaporization under inhalation conditions Release these substances into the surrounding air. Materials suitable for this purpose are known to those skilled in the art.

适当的材料为,例如,用于制备经粘膜治疗系统的活性物质贮库的聚合物材料。在该过程中,活性物质(或酸)溶于或分散于聚合的基质中(例如聚丙烯酸酯),任选地加有辅助物质,并将得到的浆状体涂覆到惰性支撑物上并使其干燥。从干燥的含有活性物质的层分割具有已知含量的活性物质或酸的一定表面积及层厚度的片。如上所述,可以将这些片作为上述制剂插入到根据本发明的装置中。装入装置的气流空间中的片状制剂的适当层厚度和表面积由药剂学实践得到。Suitable materials are, for example, polymeric materials for the production of active substance depots for transmucosal therapeutic systems. In this process, the active substance (or acid) is dissolved or dispersed in a polymeric matrix (for example polyacrylate), optionally with auxiliary substances, and the resulting slurry is applied to an inert support and Let it dry. From the dried active substance-containing layer, tablets of a certain surface area and layer thickness with a known content of active substance or acid are cut. As mentioned above, these sheets can be inserted into the device according to the invention as the formulation described above. Appropriate layer thicknesses and surface areas of tablet formulations loaded into the airflow space of the device are derived from pharmaceutical practice.

插入到根据本发明的装置中的尼古丁制剂一般具有10%重量的含量,且剂量一般为500mg。用于各个情况的浓度和剂量可以偏离这些实施例值;尤其是,活性物质含量可以为1~80%重量,且剂量为10~1000mg。The nicotine preparation inserted into the device according to the invention generally has a content of 10% by weight and the dosage is generally 500 mg. Concentrations and dosages for each case may deviate from the values of these examples; in particular, the active substance content may be from 1 to 80% by weight and dosages from 10 to 1000 mg.

适合作为聚合物基质的,尤其是选自包括聚乙烯、聚丙烯、硅酮聚合物(silicone polymers)(聚二甲基硅氧烷)和聚(甲基)丙烯酸酯的组的聚合物。Suitable as polymer matrix are especially polymers selected from the group comprising polyethylene, polypropylene, silicone polymers (polydimethylsiloxane) and poly(meth)acrylates.

而且,可以通过使用热塑性聚合物制备上述的制剂,热塑性聚合物被热液化,且成分(碱性活性物质和/或酸)被定量加入热聚物中。仍为液体的制剂被直接涂覆到深拉吸入装置用于此目的的位置处,并使其固化。Furthermore, the formulations described above can be prepared by using a thermoplastic polymer which is thermally liquefied and the ingredients (basic active substance and/or acid) are dosed into the thermal polymer. The still liquid formulation is applied directly to the place where the deep-draw inhalation device is used for this purpose and allowed to cure.

根据本发明的另一变体,硅酮聚合物(聚二甲基硅氧烷)和交联剂(例如含铂交联剂)用作基质。在冷环境下,将尼古丁碱或挥发酸组分以液体形式定量加入到上述混合物中。将预定量的此混合物涂覆于用于此目的的各个部位。封闭该装置后,在加热下后处理,从而制造了活性物质释放制剂的三维结构。According to another variant of the invention, a silicone polymer (polydimethylsiloxane) and a crosslinker (for example a platinum-containing crosslinker) are used as matrix. Under cold conditions, the nicotine base or volatile acid component is dosed into the above mixture in liquid form. A predetermined amount of this mixture is applied to each site for this purpose. After sealing the device, it was post-treated with heat, so that a three-dimensional structure of the active substance release formulation was produced.

含有活性物质或含有酸的制剂优选在各自的进气道的进气口邻近处使用。Active substance-containing or acid-containing formulations are preferably used in the vicinity of the inlet of the respective inlet.

如上所述,用于封闭装置的材料优选为如上述的对挥发性成分不渗透的材料。As mentioned above, the material used for the closure means is preferably impermeable to volatile components as described above.

在另一优选实施方案中,制造完吸入装置后,用对碱性物质不渗透的可剥离保护层覆盖。此保护层将只在临近使用前由使用者自己除掉。通过已使用的保护层,形成了含有碱性活性物质的室及含有酸的室,这两个室以基本气密的方式彼此分开且与周围的空气隔绝。如此,防止了组分的提前反应和老化。只有去除保护层后,两个室之间的气体交换才可以再发生。In another preferred embodiment, the inhalation device is covered with a peelable protective layer impermeable to alkaline substances after manufacture. This protective layer will only be removed by the user himself immediately before use. Through the protective layer that has been used, a chamber containing the alkaline active substance and a chamber containing the acid are formed, which are separated from each other and from the surrounding air in a substantially airtight manner. In this way, premature reaction and aging of the components are prevented. Only after the protective layer is removed, gas exchange between the two chambers can take place again.

如必要的话,进气和出气孔也用保护膜覆盖。If necessary, the air inlet and outlet holes are also covered with a protective film.

该装置可有利地用于戒烟,或在必要的情况下,也可以用于对尼古丁渴望的无烟的满足。The device can advantageously be used for smoking cessation or, if necessary, also for the smoke-free gratification of nicotine cravings.

具体实施方式Detailed ways

将通过实施例和附图的图示说明本发明。除非另外指明,附图标记的含义在所有附图中是相同的。The invention will be illustrated by means of examples and illustrations in the figures. Unless otherwise indicated, the meaning of the reference numerals is the same in all figures.

图1A显示根据本发明的装置(1)的市售形状(剖视图)。该装置由外壁(2)形成;它具有两个气流道(a,b),大约在该气流道的中间,其扩大形成各自的一个室(3a,3b),且此后合并形成出气道(7)。在室(3a,3b)中,分别具有含尼古丁制剂(5)和含酸制剂(4)。Figure 1A shows the commercially available shape (sectional view) of a device (1) according to the invention. The device is formed by an outer wall (2); it has two airflow channels (a, b), approximately in the middle of the airflow channels, which enlarge to form a respective chamber (3a, 3b) and thereafter merge to form an outlet airway (7 ). In the chambers (3a, 3b) there is respectively a nicotine-containing preparation (5) and an acid-containing preparation (4).

图1A显示该装置使用前的状态。气流道(a,b)的进气孔和出气孔还是关闭的,且室(3a,3b)被膜(13)彼此分开,因此两个组分(4,5)的混合还不能发生。Figure 1A shows the state of the device before use. The inlet and outlet holes of the flow channels (a, b) are still closed and the chambers (3a, 3b) are separated from each other by a membrane (13), so mixing of the two components (4, 5) cannot yet take place.

图1B显示图A中显示的装置在打开膜(13)(如通过热或通过挤过)和进气与出气孔(A,B,C)后的操作状态(同样为纵剖面图)。进气和出气孔可以例如通过沿着装置中提供的穿孔(图1A中的11、12)破开或撕下被打开(图1B中未显示层(8))。Figure 1B shows the device shown in figure A in operation (again in longitudinal section) after opening the membrane (13) (eg by heat or by squeezing) and the air inlet and outlet holes (A, B, C). The air inlet and outlet holes can be opened eg by breaking or tearing along the perforations (11, 12 in Figure IA) provided in the device (layer (8) not shown in Figure IB).

吸气时,空气一方面流经进气孔(A)和进气道(a),另一方面流经进气孔(B)和进气道(b)。虚线箭头表示吸入过程中空气的流动方向。两个进气道(a,b)合并形成具有出气孔(C)的出气道(7)。在进气道(a)的区域具有正好在进气孔(A)之后的含尼古丁制剂(5),且在进气道(b)的区域具有正好在进气孔(B)之后的含酸制剂(4)。当空气流过时,尼古丁从制剂(5)挥发进气道(a)中,而包含于制剂(4)中的酸性化合物蒸发气道(b)中。在出气道(7)的区域,碱和酸的蒸气混合,且得到了近似中性至微酸性条件。通过出气孔(C),优选经由口腔吸入形成的包括环境空气与其中所包含的尼古丁盐的气雾剂。When inhaling, the air flows through the air inlet (A) and the air inlet (a) on the one hand, and flows through the air inlet (B) and the air inlet (b) on the other hand. Dashed arrows indicate the direction of air flow during inhalation. The two inlet channels (a, b) merge to form an outlet channel (7) with an outlet hole (C). In the region of the inlet duct (a) there is a nicotine-containing formulation (5) immediately after the inlet hole (A) and in the region of the inlet channel (b) there is an acid-containing formulation just after the inlet hole (B) Formulations (4). When the air flows through, nicotine volatilizes from the preparation (5) into the airway (a), while the acidic compound contained in the preparation (4) evaporates into the airway (b). In the region of the outlet duct ( 7 ), the vapors of base and acid mix and approximately neutral to slightly acidic conditions are obtained. An aerosol comprising ambient air and nicotine salts contained therein is formed by inhalation through the vent (C), preferably via the oral cavity.

图1C显示图1B中示意性表示的吸入装置的X平面处的剖面图。进气道(a,b)通过深拉法预成型,以使它们具有凹的形状。在气槽(a,b)的区域,分别具有含活性物质制剂(5)和含酸制剂(4)。用一平的、尼古丁不渗透层(8)覆盖在所述的装置的下面。Figure 1C shows a cross-sectional view in the X-plane of the inhalation device schematically represented in Figure IB. The inlet channels (a, b) are preformed by deep drawing so that they have a concave shape. In the area of the gas channels (a, b) there is respectively an active substance-containing formulation ( 5 ) and an acid-containing formulation ( 4 ). The underside of the device is covered with a flat, nicotine impermeable layer (8).

图2A显示根据本发明的吸入装置的另一实施方案的市售形状(纵剖面)。进气和出气孔(A,B,C)仍是关闭的。槽(a,b)的中间区域扩大形成各自的室(3a,3b)。各制剂(4,5)的室(3a,3b)被并排布置,且在空间上彼此分开,以使制剂的混合还不可能(使用前的状态)。Figure 2A shows the commercially available shape (longitudinal section) of another embodiment of an inhalation device according to the invention. The inlet and outlet ports (A, B, C) are still closed. The middle areas of the grooves (a, b) are enlarged to form respective chambers (3a, 3b). The chambers ( 3a , 3b ) of the respective preparations ( 4 , 5 ) are arranged side by side and spatially separated from each other so that mixing of the preparations is not yet possible (state before use).

图2B显示图2A中所表示的吸入装置在平面X处的剖面图。进气道(a,b)和室(3a,3b)通过深拉法在外壁(2)中形成且为凹入的形状。在室(3a,3b)内分别具有含活性物质制剂(5)和含酸制剂(4)。用一平的、尼古丁不渗透层(8)覆盖所述装置的下面。Figure 2B shows a cross-sectional view at plane X of the inhalation device represented in Figure 2A. The inlet channels (a, b) and the chambers (3a, 3b) are formed in the outer wall (2) by deep drawing and are of concave shape. Inside the chambers (3a, 3b) there is respectively an active substance-containing preparation (5) and an acid-containing preparation (4). The underside of the device is covered with a flat, nicotine impermeable layer (8).

图2C为图2A和2B中所示的实施方案的另一纵剖面。该装置显示为准备使用的状态。为了使用图2A中所描述的装置,使用前沿着线(14)将其折叠,所述的线可以例如以穿孔或弱线的形式提供,从而通过沿中间折叠在纵向上使两个气流槽(a,b)和室(3a,3b)位于彼此之上。可以分别通过例如沿为此目的提供的穿孔(11,12)破开而打开进气与出气道的孔。如此得到了功能性吸入装置。虚线箭头表示吸入过程中气流的方向。管或接口管(9)可以滑移在两个出气孔(C,C′)上,从而形成联合出气道(7′)和联合出气孔(D)。Figure 2C is another longitudinal section of the embodiment shown in Figures 2A and 2B. The unit is displayed as ready to use. In order to use the device described in Figure 2A, it is folded before use along a thread (14), which may be provided, for example, in the form of a perforation or a line of weakness, so that the two airflow slots ( a, b) and chambers (3a, 3b) are located on top of each other. The holes for the inlet and outlet channels can be opened, respectively, for example by breaking through the perforations (11, 12) provided for this purpose. A functional inhalation device is thus obtained. Dashed arrows indicate the direction of airflow during inhalation. A tube or mouthpiece (9) can be slid over the two outlet holes (C, C') forming a combined outlet channel (7') and a combined outlet hole (D).

图2D显示图2C所示的操作中的装置在平面X处的剖面图。由深拉法形成的室(3a,3b)、壁(2,2′)和层(8,8′)位于彼此之上。Figure 2D shows a cross-sectional view at plane X of the device shown in Figure 2C in operation. Chambers (3a, 3b), walls (2, 2') and layers (8, 8') formed by deep drawing are located on top of each other.

图2E显示图2C所示的操作中的装置在平面Y处的剖面图。虚线箭头表示吸入过程中气流的方向。在吸入过程中,气流(A,B)流经分开的道(a,b),经过位于室(3a,3b)中的制剂(4,5)。得到的蒸气或气雾剂在由管或接口管(9)形成的出气道(7′)区域结合,并经由出气孔(D)离开装置。Figure 2E shows a cross-sectional view at plane Y of the device shown in Figure 2C in operation. Dashed arrows indicate the direction of airflow during inhalation. During inhalation, the gas streams (A, B) flow through separate channels (a, b), past the preparations (4, 5) located in the chambers (3a, 3b). The resulting vapor or aerosol combines in the region of the outlet channel (7') formed by the tube or mouthpiece (9) and leaves the device via the outlet hole (D).

图3A和3B显示根据本发明的装置的另一实施方案(余辉残留图象显示),其中图3B描绘了圆柱形插入部分(31)可以插入其中的管或接口管(30)。插入部分(31)的内部空间通过沿轴向伸展的分隔壁(32)被分成分别接收活性物质制剂和酸组分(未示出)的两个室(33,34)。该插入部分被圆柱形筒(35)围住(在图3A中其被表示为部分切开)。在后部区域,在筒中设置有孔(36);所述的孔起到进气孔的作用。在后面(38)设置有另一进气孔(37),其关闭了插入部分(31)的后部。图3C以平面图显示了该后面。孔的数量和布置可以变化。Figures 3A and 3B show another embodiment of the device according to the invention (persistence image display), wherein Figure 3B depicts the tube or mouthpiece (30) into which the cylindrical insertion part (31) can be inserted. The inner space of the insertion part (31) is divided by an axially extending partition wall (32) into two chambers (33, 34) which respectively receive the active substance preparation and the acid component (not shown). The insertion portion is enclosed by a cylindrical barrel (35) (which is shown partially cut away in Figure 3A). In the rear area, holes (36) are provided in the barrel; said holes function as air intake holes. At the rear (38) there is another air inlet (37) which closes the rear of the insertion part (31). Figure 3C shows this rear face in plan view. The number and arrangement of holes can vary.

在制造过程中,将含尼古丁制剂放置于室(33,34)中,例如,将浸有尼古丁的载体材料(如海绵或滤纸),和浸有挥发酸(优选醋酸)的载体材料放置于各自的室中;任选地,也可以随其加入调味剂或增香剂。所有的开口,即前端(V)和孔(36,37)用适当的保护膜或箔关闭。During the manufacturing process, the nicotine-containing formulation is placed in chambers (33, 34), for example, a carrier material impregnated with nicotine (such as a sponge or filter paper), and a carrier material impregnated with a volatile acid (preferably acetic acid) are placed in the respective chambers (33, 34). chamber; optionally, a flavoring or aroma enhancer may also be added therewith. All openings, ie front end (V) and holes (36, 37) are closed with suitable protective films or foils.

使用前,去除保护膜并将插入部分(31)插入接口管(30)。通过在接口管上抽吸,空气经由两个后面的孔(36,37)被吸入。该空气流经两个室(33,34)和载体,且同时带走了尼古丁蒸气、酸蒸气以及可选择地加入的增香剂蒸气。这些蒸气进入口腔前在接口管的区域中涡流。尼古丁和酸蒸气的混合促进了尼古丁吸入。为此,提供给接口管(30)多个突起或齿(39)是有利的。这些突起和齿优选接连地布置在几个偏移列中。接口管(30)为两端均开口的基本上圆柱形的套管,其优选短于插入部分(31)。Before use, the protective film is removed and the insertion part (31) is inserted into the mouthpiece (30). By suction on the mouthpiece, air is sucked in through the two rear holes (36, 37). The air flows through both chambers (33, 34) and the carrier, and simultaneously carries away nicotine vapor, acid vapor and optionally added flavorant vapor. These vapors swirl in the area of the mouthpiece before entering the mouth. The combination of nicotine and acid vapor facilitates nicotine inhalation. To this end, it is advantageous to provide the mouthpiece (30) with a plurality of protrusions or teeth (39). The protrusions and teeth are preferably arranged one after the other in several offset rows. The mouthpiece (30) is a substantially cylindrical sleeve open at both ends, which is preferably shorter than the insertion portion (31).

突起或齿(39)也可以形成为螺旋形(helical shape)、S-形或螺线形(spiral)挡板,从而达到空气更好的涡流以及气体更好的混合。The protrusions or teeth (39) can also be formed as helical shape, S-shaped or spiral baffles to achieve better swirling of the air and better mixing of the gases.

图4A显示根据本发明的装置的另一实施方案的透视图。该装置包括套管型接口管(30),管(41)可以旋转地附着于该套管型接口管上,或管(41)可以旋转滑移到其上面,或管(41)可以旋转插入其中(箭头的方向)。优选地,接口管(40)的末端被形成为一定的形状,以使当管(41)滑移到接口管上时,其可以扣合。如图3中描述的,接口管面对嘴的孔具有多个突起(39)。接口管(40)的内部空间被两个分隔壁分成四个室。接口管在两端均开口。将要与管(41)连接的开口被部分关闭。优选地,至少接口管基本为圆形的横截面的一个扇形被关闭,例如图4B中所示的两个相对的扇形。Figure 4A shows a perspective view of another embodiment of a device according to the invention. The device comprises a sleeve-type mouthpiece (30) to which a tube (41) can be rotatably attached, or the tube (41) can be rotatably slid onto it, or the tube (41) can be rotatably inserted where (the direction of the arrow). Preferably, the end of the mouthpiece (40) is shaped so that when the tube (41) is slid onto the mouthpiece, it snaps into place. As depicted in Figure 3, the mouthpiece has a plurality of protrusions (39) facing the mouth opening. The inner space of the mouthpiece (40) is divided into four chambers by two partition walls. The mouthpiece is open at both ends. The opening to be connected to the tube (41) is partially closed. Preferably, at least one sector of the substantially circular cross-section of the mouthpiece is closed, such as the two opposing sectors shown in Figure 4B.

滑移管(41)在两端均开口,且在内部以与接口管相同的方式(通过壁(44,45)的方式)被分隔成四个室。含尼古丁制剂和含酸制剂分别位于两个相对的室中。The slide tube (41) is open at both ends and internally divided into four chambers in the same way as the mouthpiece (by means of walls (44, 45)). The nicotine-containing formulation and the acid-containing formulation are respectively located in two opposing chambers.

还提供了接口管和管被分隔成2个或3个、或多于4个内部空间的实施方案。Embodiments are also provided where the mouthpiece and tube are divided into 2 or 3, or more than 4 interior spaces.

壁或挡板(44,45)还可以形成为螺旋形、S-形或螺线形,从而达到更强烈的空气涡流,并因此达到更好的气体混合。The walls or baffles (44, 45) can also be formed helically, S-shaped or helically in order to achieve a stronger air vortex and thus better gas mixing.

通过在管的第一室中插入含尼古丁载体材料,和在相应的对面的室中插入含酸载体材料制备了含尼古丁管(任选地用增香剂改良)。然后所有的开口用适当的膜或箔关闭。此外,可以用另外的活性物质或增香剂填充管的其余的室。Nicotine-containing tubes (optionally modified with flavoring agents) are prepared by inserting a nicotine-containing carrier material in a first chamber of the tube, and an acid-containing carrier material in the corresponding opposite chamber. All openings are then closed with suitable membranes or foils. Furthermore, the remaining chambers of the tube can be filled with further active substances or fragrances.

使用时,去除保护膜并将管(41)滑移到接口管(40)上,从而扣合。该管被旋转啮合,以使通过相对于接口管旋转管(见双箭头)时,填充的室可以打开和关闭。这使消费者可以调节希望吸入的气流。如果必要的话,接口管的开口端,和管的开口端各自可以用可拆卸的帽关闭。In use, the protective film is removed and the tube (41 ) is slid onto the mouthpiece (40), thereby snapping. The tube is rotationally engaged so that the filled chamber can be opened and closed by rotating the tube relative to the mouthpiece (see double arrow). This allows the consumer to adjust the airflow they wish to inhale. If necessary, the open end of the mouthpiece, and the open end of the tube can each be closed with a detachable cap.

图5显示(横截面)图4中描述的实施方案的一种变化。接口管(40)和管(41)的内部空间被分成四个管状室(51、52、53、54);(50)分别指接口管和管的圆柱形壁。FIG. 5 shows (in cross section) a variation of the embodiment described in FIG. 4 . The inner space of mouthpiece (40) and tube (41) is divided into four tubular chambers (51, 52, 53, 54); (50) refer to the cylindrical walls of mouthpiece and tube, respectively.

在这种情况下,浸有活性物质或酸的载体材料以“药筒”的形式插入管中是有利的。在此情况下,管可以形成具有接口管且与其永久地(但可旋转地)相连的装置,这意味着整个装置是可重复利用的。所述的“药筒”可以独立储存,且可以制备以具有不同的尼古丁含量(或以含有不同的活性物质)。In this case, it is advantageous for the carrier material impregnated with active substance or acid to be inserted into the tube in the form of a "cartridge". In this case, the tube may form a device with a mouthpiece to which it is permanently (but rotatably) connected, which means that the whole device is reusable. The "cartridges" can be stored independently, and can be manufactured to have different nicotine levels (or to contain different active substances).

图6以图示表示根据本发明的装置的另一有利的实施方案。含活性物质制剂(未示出)位于第一室(61),其形成活性物质蒸气可以积聚在其中的较大的气体空间。可与增香剂组合的含酸制剂位于第二室(62)。宽箭头表示吸入过程中出现的气流的方向。空气经过进气孔(64,65)被吸入。这些孔可以具有阀,以防止组分(活性物质、酸)过早混合或/和防止组分漏到外面。FIG. 6 schematically shows another advantageous embodiment of the device according to the invention. The active substance-containing preparation (not shown) is located in the first chamber (61), which forms a large gas space in which the active substance vapor can accumulate. An acid containing formulation that can be combined with a flavoring agent is located in the second chamber (62). Broad arrows indicate the direction of airflow occurring during inhalation. Air is drawn in through the air intake holes (64, 65). These holes may have valves to prevent premature mixing of components (active substances, acids) or/and leakage of components to the outside.

通过接口管(63)吸入时,空气沿着两个不同的路径流进装置:(i)空气通过侧面的孔(64)流进室(61)中,且在该过程中空气将蒸气压预饱和的气体空间冲进接口管(63)前面的混合区。(ii)同时,空气通过侧面的孔(65)被吸入第二室(62)中。在该过程中,气体也将辅助物质(酸,可能的调味剂)冲进接口管(63)前面的混合区。在该混合区,两个气流彼此混合。在该混合过程中,发生预期的活性物质碱的中和作用。When inhaled through mouthpiece (63), air flows into the device along two different paths: (i) air flows into chamber (61) through side holes (64), and in the process the air pre-sets the vapor pressure. The saturated gas space rushes into the mixing zone in front of the mouthpiece (63). (ii) Simultaneously, air is sucked into the second chamber (62) through the side holes (65). During this process, the gas also rushes auxiliary substances (acids, possibly flavorings) into the mixing zone in front of the mouthpiece (63). In this mixing zone, the two gas streams mix with each other. During this mixing, the desired neutralization of the active substance base takes place.

Claims (28)

1. give the suction apparatus of human or animal body alkalescence active material by the mode that sucks, wherein said suction apparatus comprises:
Comprise nicotine alkali or/and first preparation of another alkaline active material;
Second or a plurality of other preparation, described second or a plurality of other preparation at least one comprise at least a volatile acid that is suitable for sucking;
It is characterized in that, described suction apparatus has first air admission hole, second air admission hole and venthole, mainly flow through described first preparation so that flow to the air-flow of first air admission hole, and the air-flow that flows to second air admission hole mainly flows through described second or other preparation, these two air-flows merge on its path subsequently, and leave this suction apparatus through described venthole; And be, describedly comprise nicotine alkali and comprise described nicotine alkali or/and the polymer substrate of another alkaline active material or/and first preparation of another alkaline active material has wherein with the dissolving or the form of disperseing, and/or described second or a plurality of other preparation that comprises at least a volatile acid that is suitable for sucking have wherein the polymer substrate that comprises the described volatile acid that is suitable for sucking with the dissolving or the form of disperseing, and the polymer substrate of described first preparation and described second or the polymer substrate of a plurality of other preparations all comprise polyethylene based on being selected from, polypropylene, polymer in the group of silicone polymer and poly-(methyl) acrylate.
2. suction apparatus according to claim 1 is characterized in that, use the position that described first preparation and second preparation or a plurality of other preparation separate in this suction apparatus.
3. suction apparatus according to claim 1 is characterized in that, described first preparation comprises the nicotine alkali that combines with at least a solvent that is suitable for sucking or/and another alkaline active material.
4. suction apparatus according to claim 1 is characterized in that, the described volatile acid that is suitable for sucking combines and is contained in described second preparation or described a plurality of other preparation with at least a solvent that is suitable for sucking.
5. according to claim 3 or 4 described suction apparatus, it is characterized in that the described solvent that is suitable for sucking is an ethanol.
6. suction apparatus according to claim 1 is characterized in that, the described volatile acid that is suitable for sucking is to be selected from the group that comprises acetic acid, lactic acid, malic acid and propionic acid.
7. suction apparatus according to claim 1 is characterized in that, in suction process, nicotine alkali and the volatile acid that is suitable for sucking discharge from described first preparation and described second preparation or described a plurality of other reagent respectively with approximate equimolar amounts.
8. suction apparatus according to claim 1, it is characterized in that, continuing 1~10s and reaching in the suction process of air-breathing speed of 0.1~1l/min, described suction apparatus discharges nicotine alkali or another the alkaline active material of 5~250 μ g from described first preparation to inhaled air.
9. suction apparatus according to claim 8 is characterized in that, described suction apparatus discharges the nicotine alkali of 10~100 μ g or/and another alkaline active material from described first preparation to inhaled air.
10. suction apparatus according to claim 1 is characterized in that, in suction process, forms aerosol particles in the inner space of described suction apparatus.
11. suction apparatus according to claim 10 is characterized in that, the size of described aerosol particles is less than 10 μ m.
12. suction apparatus according to claim 1 is characterized in that, described first preparation and/or described second preparation or described a plurality of other preparation comprise at least a other volatile and additive that is suitable for sucking.
13. suction apparatus according to claim 12 is characterized in that, described other additive is a menthol.
14. suction apparatus according to claim 1 is characterized in that, this suction apparatus is at least in part by for the impervious material manufacturing of described alkaline active material.
15. suction apparatus according to claim 1 is characterized in that, this suction apparatus is fully by for the impervious material manufacturing of described alkaline active material.
16. according to claim 14 or 15 described suction apparatus, it is characterized in that, describedly be selected from for the impervious material of described alkaline active material: be coated with the polyester material of acrylonitrile and methacrylate copolymer, and/or the combination of metal forming or above-mentioned material.
17. suction apparatus according to claim 1; it is characterized in that; after this suction apparatus manufacturing and in storing; with the impervious peelable protective layer of alkaline active material is covered; thereby formed the chamber of containing alkaline active material and the chamber of containing the acid that is suitable for sucking by this peelable protective layer, these two chambers are separated from each other in airtight mode and are isolated with surrounding air.
18. suction apparatus according to claim 1 is characterized in that, the cross-section of pipeline of air admission hole and venthole forms and makes that the negative dividing potential drop in the oral cavity mostly is 300Pa most in suction process.
19. suction apparatus according to claim 1 is characterized in that, the cross-section of pipeline of air admission hole and venthole forms and makes that the negative dividing potential drop in the oral cavity mostly is 200Pa most in suction process.
20. suction apparatus according to claim 1, it is characterized in that, this suction apparatus comprises at least one by the molded component that deep drawing methods is made, and wherein has the microscler recess that forms first air intake duct and second air intake duct and pass through to merge the gas off-take of these two air flues formation.
21. suction apparatus according to claim 20, it is characterized in that, this suction apparatus has top and the bottom that respectively forms by deep drawing methods, these two molded components have described microscler recess and are connected to each other in following mode: by microscler recess positioned opposite to each other, formed first air intake duct with first air admission hole and second air intake duct with second air admission hole, and by the gas off-take with venthole in conjunction with these two air intake ducts.
22., it is characterized in that described first preparation is arranged in the microscler recess that forms first air intake duct according to claim 20 or 21 described suction apparatus, and described second preparation is arranged in the microscler recess that forms second air intake duct.
23. make according to each the method for suction apparatus in the claim 1~22, this method may further comprise the steps:
Make molded component, described molded component comprises the first microscler recess that receives described first preparation, and receives the second microscler recess of described second preparation;
First preparation that contains nicotine alkali or another alkaline active material of scheduled volume is put into the described first microscler recess;
Second preparation of the acid that is suitable for sucking containing of scheduled volume is put into the described second microscler recess.
24. method according to claim 23; it is characterized in that; the molded component of filling is used the impervious peelable protective layer of alkaline active material is covered; thereby form the chamber that contains the chamber of this alkalescence active material and contain the acid that is suitable for sucking by peelable protective layer, these two chambers are separated from each other in airtight mode and are isolated with ambient air.
25. according to claim 23 or 24 described methods, it is characterized in that, in the molded component manufacture process, formed a microscler recess again that is connected and forms air flue with the described first microscler recess with the described second microscler recess by deep drawing methods.
26. method according to claim 25, it is characterized in that, the molded component of filling be connected as top and molded component with microscler recess corresponding with the recess of the molded component of described filling, thereby form first air intake duct by recess separately, stacked with first air admission hole, second air intake duct with second air admission hole, and gas off-take with venthole.
27. be used to give up smoking or be used for the smokeless application of satisfying that nicotine is craved for according to each the suction apparatus in the claim 1~22.
28. be used for sucking simultaneously alkaline active material and one or more volatile acid application of compound according to each the suction apparatus in the claim 1~22.
CN2004800361875A 2003-12-05 2004-11-16 Alkaline drug inhaler and its manufacturing method Expired - Fee Related CN1889861B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10356925A DE10356925B4 (en) 2003-12-05 2003-12-05 Inhaler for basic active pharmaceutical ingredients and process for its preparation
DE10356925.1 2003-12-05
PCT/EP2004/012947 WO2005053444A1 (en) 2003-12-05 2004-11-16 Inhaler for basic pharmaceutical agents and method for production thereof

Publications (2)

Publication Number Publication Date
CN1889861A CN1889861A (en) 2007-01-03
CN1889861B true CN1889861B (en) 2010-11-17

Family

ID=34638403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800361875A Expired - Fee Related CN1889861B (en) 2003-12-05 2004-11-16 Alkaline drug inhaler and its manufacturing method

Country Status (7)

Country Link
US (1) US20070062548A1 (en)
EP (1) EP1699309A1 (en)
JP (1) JP4516970B2 (en)
CN (1) CN1889861B (en)
CA (1) CA2546693A1 (en)
DE (1) DE10356925B4 (en)
WO (1) WO2005053444A1 (en)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US9675109B2 (en) 2005-07-19 2017-06-13 J. T. International Sa Method and system for vaporization of a substance
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
DE202006001663U1 (en) * 2006-02-03 2006-04-27 Kieslich, Dirk Smoke-free cigarette with nicotine and flavor cushions but without harmful combustion substances and side effects
WO2008062453A2 (en) * 2006-09-25 2008-05-29 Nikki Nikhilesh Singh Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form
GB2461008B (en) * 2006-12-08 2011-08-10 Exchange Supplies Ltd Nicotine inhalation device
JP2010532672A (en) * 2007-03-30 2010-10-14 デューク ユニバーシティ Apparatus and method for delivering medication
KR101199638B1 (en) 2007-11-30 2012-11-08 니뽄 다바코 산교 가부시키가이샤 Aerosol-generating solution for aerosol aspirator
PT2230934E (en) 2007-12-14 2012-11-20 Aerodesigns Inc Delivering aerosolizable food products
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
AT507187B1 (en) 2008-10-23 2010-03-15 Helmut Dr Buchberger INHALER
NZ594585A (en) 2009-03-17 2014-01-31 Philip Morris Prod Tobacco-based nicotine aerosol generation system
US8495998B2 (en) 2009-06-17 2013-07-30 British American Tobacco (Investments) Limited Inhaler
SE534196C2 (en) * 2009-06-29 2011-05-31 John Wollin Nicotine dosing system
MY163517A (en) 2009-09-16 2017-09-15 Philip Morris Products Sa Improved device and method for delivery of a medicament
GB0918129D0 (en) 2009-10-16 2009-12-02 British American Tobacco Co Control of puff profile
DE102010000043A1 (en) 2010-01-11 2011-07-14 Lars 12587 Dähne Inhaler system for volatile substances
AT508244B1 (en) 2010-03-10 2010-12-15 Helmut Dr Buchberger INHALATORKOMPONENTE
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
PL2552245T3 (en) 2010-03-26 2019-05-31 Philip Morris Products Sa INHIBITION OF SENSORY IRRITATION DURING CONSUMPTION OF FLAMMABLE Tobacco Products
ES2922200T3 (en) 2010-08-24 2022-09-09 Jt Int Sa Inhalation device including substance use controls
AU2012214085B2 (en) 2011-02-11 2015-07-09 Nicoventures Trading Limited Inhaler component
AT510837B1 (en) 2011-07-27 2012-07-15 Helmut Dr Buchberger INHALATORKOMPONENTE
CN107259647B (en) 2011-09-06 2020-03-20 英美烟草(投资)有限公司 Heating smokable material
KR102196913B1 (en) 2011-09-06 2020-12-30 니코벤처스 트레이딩 리미티드 Heating smokeable material
DE102011083183A1 (en) * 2011-09-22 2013-03-28 Elke Martschina Smokeless cigarette has depot element which is inserted between two ends of contour sleeve made of heat conducting metal material, and cigarette tube is pushed into contour sleeve
AT511344B1 (en) 2011-10-21 2012-11-15 Helmut Dr Buchberger INHALATORKOMPONENTE
TW201340894A (en) * 2011-12-20 2013-10-16 British American Tobacco Co Smoking articles and other flow delivery articles
AU2013222232A1 (en) 2012-02-22 2014-09-04 Altria Client Services Inc. Electronic smoking article
PL2836090T3 (en) * 2012-04-12 2019-07-31 Jt International Sa Aerosol-generating devices
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
US10021907B2 (en) * 2014-11-20 2018-07-17 Kaloud, Inc. Hookah bowl
US20160143352A1 (en) * 2012-06-06 2016-05-26 Kaloud, Inc. Head bowl accessory for a water pipe
US10004259B2 (en) * 2012-06-28 2018-06-26 Rai Strategic Holdings, Inc. Reservoir and heater system for controllable delivery of multiple aerosolizable materials in an electronic smoking article
GB2504075A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
GB2504076A (en) 2012-07-16 2014-01-22 Nicoventures Holdings Ltd Electronic smoking device
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
WO2014115324A1 (en) * 2013-01-28 2014-07-31 日本たばこ産業株式会社 Non-heating flavor suction device
US10031183B2 (en) 2013-03-07 2018-07-24 Rai Strategic Holdings, Inc. Spent cartridge detection method and system for an electronic smoking article
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US20140261488A1 (en) * 2013-03-15 2014-09-18 Altria Client Services Inc. Electronic smoking article
GB2513637A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
GB2513639A (en) 2013-05-02 2014-11-05 Nicoventures Holdings Ltd Electronic cigarette
MX384606B (en) * 2013-05-06 2025-03-12 Juul Labs Inc Nicotine salt formulations for aerosol devices and methods thereof
WO2014190079A2 (en) * 2013-05-22 2014-11-27 Njoy, Inc. Compositions, devices, and methods for nicotine aerosol delivery
GB2514893B (en) 2013-06-04 2017-12-06 Nicoventures Holdings Ltd Container
CN111642812A (en) 2013-06-14 2020-09-11 尤尔实验室有限公司 Multiple heating elements with individual vaporizable materials in electronic vaporization devices
WO2015009863A1 (en) * 2013-07-19 2015-01-22 Altria Client Services Inc. Electronic smoking article
US9848645B2 (en) 2013-07-24 2017-12-26 Sis Resources Ltd. Cartomizer structure for automated assembly
RU2533949C1 (en) * 2013-09-09 2014-11-27 Дмитрий Анатольевич Семаков Volatile drug inhaler
JP6386563B2 (en) * 2013-09-19 2018-09-05 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Aerosol generation system for generating nicotine salt particles
CA3144602A1 (en) 2013-12-05 2015-06-11 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US9549573B2 (en) 2013-12-23 2017-01-24 Pax Labs, Inc. Vaporization device systems and methods
DE202014011309U1 (en) 2013-12-23 2019-03-29 Juul Labs Uk Holdco Limited Systems for an evaporation device
ES2526106B1 (en) 2014-02-21 2016-05-06 Armando MEDINA RIVERO DEVICE FOR TESTING ELECTRONIC CIGARETTE LIQUIDS
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
SG11201608974RA (en) 2014-04-28 2016-11-29 Philip Morris Products Sa Nicotine powder inhaler
RU2680422C2 (en) 2014-04-28 2019-02-21 Филип Моррис Продактс С.А. Flavoured nicotine powder inhaler
MY181763A (en) 2014-04-28 2021-01-06 Philip Morris Products Sa Nicotine powder inhaler
US11478021B2 (en) 2014-05-16 2022-10-25 Juul Labs, Inc. Systems and methods for aerosolizing a vaporizable material
TWI669073B (en) * 2014-06-24 2019-08-21 瑞士商菲利浦莫里斯製品股份有限公司 Aerosol-generating system, aerosol-generating article, aerosol-generating device and method of controlling the reaction stoichiometry
GB2528673B (en) 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
GB2529201A (en) 2014-08-13 2016-02-17 Batmark Ltd Device and method
US11350669B2 (en) 2014-08-22 2022-06-07 Njoy, Llc Heating control for vaporizing device
CN107427067B (en) 2014-12-05 2020-10-23 尤尔实验室有限公司 Corrective dose control
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201501951D0 (en) 2015-02-05 2015-03-25 Jt Int Sa Aerosol guiding device and aerosol generating system comprising said aerosol guiding device
US10786007B2 (en) * 2015-03-27 2020-09-29 Philip Morris Products S.A. Resealable aerosol-generating article
GB201505597D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Article for use with apparatus for heating smokable material
GB201505595D0 (en) 2015-03-31 2015-05-13 British American Tobacco Co Cartridge for use with apparatus for heating smokeable material
EP3289895B1 (en) * 2015-05-01 2021-11-17 Japan Tobacco Inc. Non-combustion type flavor inhaler
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US10251425B2 (en) 2015-07-06 2019-04-09 Njoy, Llc Vaporizing device with power component
USD809190S1 (en) 2015-07-13 2018-01-30 Njoy, Llc Vaporizer
US10039323B2 (en) 2015-07-16 2018-08-07 Njoy, Llc Vaporizer tank with atomizer
CN108348705B (en) * 2015-07-20 2021-06-29 医疗发展国际有限公司 Inhaler device for inhalable liquids
JP7044702B2 (en) * 2015-07-20 2022-03-30 メディカル、ディベロップメンツ、インターナショナル、リミテッド Inhaler device for inhalable liquids
WO2017011865A1 (en) 2015-07-20 2017-01-26 Medical Developments International Limited Inhaler device for inhalable liquids
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
US12042809B2 (en) 2015-11-02 2024-07-23 Altria Client Services Llc Aerosol-generating system comprising a vibratable element
RU2713326C2 (en) * 2015-11-02 2020-02-04 Филип Моррис Продактс С.А. Aerosol-generating system comprising vibration element
CN108289512A (en) * 2015-12-21 2018-07-17 菲利普莫里斯生产公司 Aerosol generating system including variable air inlet
SI3183979T1 (en) 2015-12-22 2018-07-31 Philip Morris Products S.A. Cartridge for an aerosol-generating system and an aerosol-generating system comprising a cartridge
PL3183980T3 (en) * 2015-12-22 2019-02-28 Philip Morris Products S.A. A cartridge for an aerosol-generating system and an aerosol-generating system comprising a cartridge
WO2017108987A1 (en) * 2015-12-22 2017-06-29 Philip Morris Products S.A. A cartridge for an aerosol-generating system and an aerosol-generating system comprising a cartridge
KR102654085B1 (en) * 2015-12-22 2024-04-04 필립모리스 프로덕츠 에스.에이. Cartridges for aerosol-generating systems and aerosol-generating systems including cartridges
US11229758B2 (en) * 2016-01-11 2022-01-25 Syqe Medical Ltd. Personal vaporizing device with slidable cart
WO2017139595A1 (en) 2016-02-11 2017-08-17 Pax Labs, Inc. Fillable vaporizer cartridge and method of filling
SG11201806801VA (en) 2016-02-11 2018-09-27 Juul Labs Inc Securely attaching cartridges for vaporizer devices
GB201602831D0 (en) * 2016-02-18 2016-04-06 British American Tobacco Co Flavour delivery device
US10455863B2 (en) 2016-03-03 2019-10-29 Altria Client Services Llc Cartridge for electronic vaping device
US10433580B2 (en) 2016-03-03 2019-10-08 Altria Client Services Llc Methods to add menthol, botanic materials, and/or non-botanic materials to a cartridge, and/or an electronic vaping device including the cartridge
US10368580B2 (en) 2016-03-08 2019-08-06 Altria Client Services Llc Combined cartridge for electronic vaping device
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
US10357060B2 (en) 2016-03-11 2019-07-23 Altria Client Services Llc E-vaping device cartridge holder
US10368581B2 (en) 2016-03-11 2019-08-06 Altria Client Services Llc Multiple dispersion generator e-vaping device
US12501928B2 (en) 2016-03-11 2025-12-23 Altria Client Services Llc Multiple dispersion generating e-vaping device having a dual piston cylinder, configured to reduce a transmission of a pressure force from a carbon dioxide capsule to a tank configured to store a pre-aerosol formulation
WO2017187148A1 (en) 2016-04-27 2017-11-02 Nicoventures Holdings Limited Electronic aerosol provision system and vaporizer therefor
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
CN106063583A (en) * 2016-07-14 2016-11-02 深圳昱朋科技有限公司 The preparation method of ree-oil additive and ree-oil
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
EP3550998A1 (en) 2016-12-12 2019-10-16 VMR Products LLC Vaporizer cartridge
GB201702206D0 (en) 2017-02-10 2017-03-29 British American Tobacco Investments Ltd Vapour provision system
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
GB201721477D0 (en) 2017-12-20 2018-01-31 British American Tobacco Investments Ltd Electronic aerosol provision system
GB201721470D0 (en) 2017-12-20 2018-01-31 British American Tobacco Investments Ltd Electronic aerosol provision system
GB201721447D0 (en) 2017-12-20 2018-01-31 British American Tobacco Investments Ltd Electronic aerosol provision system
BR112020024137A2 (en) * 2018-06-21 2021-02-17 Philip Morris Products S.A. activated and resealable cartridge assembly for an aerosol generating system
US20220167668A1 (en) * 2019-03-11 2022-06-02 Nicoventures Trading Limited Aerosol generation
US11998050B2 (en) * 2020-06-23 2024-06-04 Altria Client Services Llc Capsules with internal channels, heat-not-burn (HNB) aerosol-generating devices, and methods of generating an aerosol
CN115956053A (en) * 2020-08-25 2023-04-11 维克多瑞传送设备有限公司 Unit dose dry powder inhaler
KR102527343B1 (en) * 2020-10-23 2023-05-02 주식회사 케이티앤지 Aerosol generating article comprising liquid composition and aerosol generating system comprising the same
US20250049109A1 (en) * 2021-12-20 2025-02-13 Nicoventures Trading Limited A consumable for use with an aerosol provision device
KR102728724B1 (en) * 2022-07-26 2024-11-11 주식회사 케이티앤지 Aerosol generating device
CN120731022A (en) * 2022-12-23 2025-09-30 菲利普莫里斯生产公司 Aerosol-generating article comprising a frame

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86103434A (en) * 1985-05-24 1986-11-26 高级烟草制品公司 The nicotine dispenser of band polymeric reservoir of nicotine
US4765348A (en) * 1986-12-12 1988-08-23 Brown & Williamson Tobacco Corporation Non-combustible simulated cigarette device
US5660169A (en) * 1990-09-12 1997-08-26 Astra Aktiebolag Disposable inhaler with pull-off seal
GB2388040A (en) * 2002-05-02 2003-11-05 Robert Jeremy West Variable dosage nicotine inhaler

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US726037A (en) * 1901-06-22 1903-04-21 Henry Ferre Tubular inhaler.
GB1017032A (en) * 1963-12-12 1966-01-12 Aerosmoke Ltd Aerosol compositions
US4284089A (en) * 1978-10-02 1981-08-18 Ray Jon P Simulated smoking device
AT384552B (en) * 1985-08-01 1987-12-10 Hurka Wilhelm INHALATION DEVICE FOR DOSING AND DISTRIBUTING SOLID BODIES INTO THE BREATHING AIR
US4793366A (en) * 1985-11-12 1988-12-27 Hill Ira D Nicotine dispensing device and methods of making the same
US4917120A (en) * 1986-05-21 1990-04-17 Advanced Tobacco Products, Inc. Nicotine impact modification
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5441060A (en) * 1993-02-08 1995-08-15 Duke University Dry powder delivery system
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE19546024C2 (en) * 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermal pharmaceutical preparation and its production
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
CA2462576A1 (en) * 2001-11-21 2003-06-03 Alexza Molecular Delivery Corporation Open-celled substrates for drug delivery
EP1663168B1 (en) * 2003-09-08 2009-02-11 McNeil AB Nicotine formulations and use thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86103434A (en) * 1985-05-24 1986-11-26 高级烟草制品公司 The nicotine dispenser of band polymeric reservoir of nicotine
US4765348A (en) * 1986-12-12 1988-08-23 Brown & Williamson Tobacco Corporation Non-combustible simulated cigarette device
US5660169A (en) * 1990-09-12 1997-08-26 Astra Aktiebolag Disposable inhaler with pull-off seal
GB2388040A (en) * 2002-05-02 2003-11-05 Robert Jeremy West Variable dosage nicotine inhaler

Also Published As

Publication number Publication date
DE10356925A1 (en) 2005-07-14
US20070062548A1 (en) 2007-03-22
WO2005053444A1 (en) 2005-06-16
CN1889861A (en) 2007-01-03
JP4516970B2 (en) 2010-08-04
JP2007512880A (en) 2007-05-24
CA2546693A1 (en) 2005-06-16
EP1699309A1 (en) 2006-09-13
DE10356925B4 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
CN1889861B (en) Alkaline drug inhaler and its manufacturing method
RU2735143C2 (en) Nicotine powder delivery system
AU771926B2 (en) Systems and methods for aerosolizing pharmaceutical formulations
AU2002255808B2 (en) Inhalation device and method
CA2598953C (en) Nasal delivery device for delivering substance to a nasal cavity of a subject
US20190247607A1 (en) Inhalator
US20120132204A1 (en) Unit dose dry powder inhaler
JPH0271760A (en) Inhalation metering type drug aerosol distribution and administration apparatus
US20080142010A1 (en) Systems, methods, and apparatuses for pulmonary drug delivery
CN111526747B (en) dry powder inhaler
JP2002506698A (en) Dry powder drug inhaler with inhalation actuated flow diversion means to trigger drug delivery
CZ408997A3 (en) Inhaling apparatus
HU220450B1 (en) Dry powder inhaler
CN108348704A (en) Inhaler device for may be inhaled liquid
CN111801026A (en) Inhaler with perforated porous support element
BR112018075142B1 (en) ARTICLE FOR USE IN A NICOTINE INHALER AND INHALER
HUP0004053A2 (en) Method of implementing halotherapy
WO2016168276A1 (en) Flavoring element for an inhalation device
US7465287B2 (en) Apparatus for dispensing powdered material
GB2310607A (en) Spacer device for inhalers
US6981660B2 (en) Shock wave aerosolization apparatus and method
CN106255524B (en) Inhalation device for inhaling powder
CN110300610A (en) Inhaler device for inhalable liquids
MXPA98000223A (en) Device and method of inhalac

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101117

Termination date: 20121116